Browsing Tag
biopharmaceutical acquisition
2 posts
Eli Lilly to acquire Morphic in $3.2bn deal to expand integrin therapy development
In a major strategic move, Eli Lilly and Company (NYSE: LLY) has announced a definitive agreement to acquire…
Hasten Biopharmaceutical buys asset rights for 14 branded products from Celltrion
In a significant move, CBC Group, Asia’s largest healthcare-dedicated asset management firm headquartered in Singapore, announced that its…